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Background: Germ cell development involves formation of the spermatogenic or oogenic lineages from the
bipotential primordial germ cells. Signaling mechanisms in the fetal testis and ovary determine whether germ cells
enter the male or female developmental pathway, respectively. These signaling processes underpin an important
phase of germ cell development, disruption of which can lead to failed germ cell function resulting in infertility or
the formation of germ cell tumours.
Findings: In this study we have developed a small molecule screening protocol combined with flow cytometry to
identify signaling pathways that direct male-specific development of germ cells. Here we provide a detailed
method for this screening protocol, which we have used to identify signaling pathways important for male germ
cell development.
Conclusion: This method will be of particular use in screening inhibitors of signaling pathways, endocrine
disruptors or other chemicals for their ability to disrupt testis and germ cell development, thereby providing insight
into testicular dysgenesis and factors underlying poor male reproductive health.
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Spermatogenesis and oogenesis are founded on the de-
velopment of the male and female germ cell lineages in
the developing fetus. In mammals, primordial germ cells
are specified from the pluripotent epiblast in the pre-
gastrulation embryo [1]. The primordial germ cells mi-
grate through the embryo and populate the developing
gonads at approximately embryonic day (E) 10.5. At this
stage, germ cells express key regulators of pluripotency
and can readily establish pluripotent embryonic germ
cell lines in vitro, reflecting their ability to retain germ
line totipotency [2-5]. After entering the developing
testes or ovary the germ cells differentiate down the
spermatogenic or oogenic pathways in response to their
respective environments [6-9]. The molecular pathways
directing male and female germ line development are
poorly understood, even though these processes are* Correspondence: patrick.western@monash.edu
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reproduction in any medium, provided the orcrucial for later fertility and for preventing germ cell
tumours.
Testis development is initiated with the expression of
Sex Region Y chromosome (Sry), which activates Sry box
gene 9 (Sox9), thereby promoting specification and prolifer-
ation of Sertoli cells and a cascade of events culminating in
testis differentiation [10-12]. Sertoli cells proliferate and
form testis cords, which enclose the fetal germ cells and de-
fine the interstitial space in which Leydig cell differentiation
occurs [10,13]. These somatic cell types promote testis
development and differentiation of the male germ line.
At the onset of testis or ovary development the germ
cells can enter the male or female developmental path-
way, regardless of whether they are genetically male
(XY) or female (XX). The earliest indication of male and
female germ cell development is their entry into mitotic
arrest or meiosis, which occurs from E12.5 and E13.5,
respectively [8]. Experimental evidence collected over
the last three decades demonstrate that male and female
germ cells are responsive to signals from the gonadalal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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by E12.5 and E13.5, respectively [6,8,9,14].
The signaling mechanisms leading to male germ cell de-
velopment and regulating testis development are not fully
understood. However, germ cell mitotic arrest occurs in
48 hours from approximately E12.5, depending on the
mouse strain [15,16]. Mitotic arrest of male germ cells in-
volves activation of a number of G1-S phase check-point
controlling proteins, including Retinblastoma and p27KIP1
[15,17]. Male germ cell differentiation also involves the
repression of the core pluripotency genes Oct4, Sox2 and
Nanog, which are maintained in germ cell derived terato-
mas [4,5,18-20].
We have previously analysed male germ cell develop-
ment using flow cytometry [15,16,21]. In this study we
aimed to develop an ex-vivo screening protocol for iden-
tifying signaling pathways involved in male germ cell de-
velopment with the expectation that disrupting these
signaling processes would block male germ cell mitotic
arrest and differentiation, without causing sex-reversal.
We isolated E12.5 fetal testes after male sex determin-
ation had occurred and testis cords had formed, but be-
fore germ cells had entered mitotic arrest [15,16]. These
fetal testes were cultured with a range of specific small
molecule chemical inhibitors and germ cell mitotic ar-
rest was monitored using a flow cytometric assay. Here
we provide a detailed account of this protocol and its
application in screening small molecule inhibitors for
their ability to disrupt mouse fetal germ cell or gonad
development. This system provides an effective medium
throughput, ex-vivo model for identifying small mole-
cules or chemicals, such as endocrine disruptors, that
inhibit germ cell mitotic arrest, reflecting compromised




 Click-iT-EdU 647 Flow Cytometry kit (Molecular
Probes/Life Technologies C10424)
 Bovine Serum Albumen (BSA)
 Donkey serum
 Propidium Iodide 5 mg/ml in water
 RNaseA 20 mg/ml
 Phosphate Buffered Saline (PBS)
 Rabbit-anti-Mouse Vasa Homologue (MVH)
antibody (AbCam Ab13840). It is advisable to
perform a trial run to check your antibody stock and
dilution prior to undertaking a larger experiment.
 Alexa fluor donkey-anti-rabbit 488 nm secondary
antibody (Molecular Probes/Life Technologies;
A21206)
 Cell culture medium Inhibitors reconstituted to appropriate
concentration allowing at least 1 in 1000 dilution if
in DMSO. We start with a concentration 10 × the
IC50 for each inhibitor, or as otherwise
recommended by the manufacturer. Do not use
DMSO in cultures at less than 1 in 1000 dilution as
it will affect the culture.
 Organ culture filters: 25 mm polycarbonate,
polyvinyl pryolidine free (PVPF) filters, 12.0 micron
pore size (GE Water and Process Technologies
Catalogue number K12SH02500)
 Organ culture dishes (Nunc 353037) containing
1500 μl organ culture media
 Laminar flow hood, dissecting microscope and
instruments
 Timed mated pregnant female mice or appropriate
strain or line. We routinely use Oct4-GFP transgenic
mice as these allow visualisation of the germ cells.
 Flow cytometer, micro-centrifuge, shaking heating
block/water bath, cell culture incubator, 1.5 ml
micro-centrifuge tubes etc.
Culture medium
DMEM/F12 with glutamax: (Gibco/Life Technologies
10565)
10% Fetal Calf Serum: (or serum replacement; Gibco
10828)
15 mM Hepes: (1M stock; Gibco 15630)
1 × NEAA: (100× stock; Gibco 11140)
1 mg/ml N-acetyl-cysteine: (100× stock 100 mg/ml in
water; Sigma A9165)
55 uM β-mercapto-ethanol: (1000× stock; Gibco 21985)
1 × Pen/Strep: (100× stock; Gibco 15070)
Mice and tissue collection
All embryos used in the following protocols were derived
from OG2 (Oct4-GFP) transgenic male × CD1 female mat-
ings. Mice were housed on a twelve-hour light/dark cycle.
Mating was detected by the presence of a vaginal plug in
the morning and recorded as E0.5. Embryos were sexed
and staged according to morphological criteria. All animal
procedures were carried out under approval of Monash
University Animal Ethics or Murdoch Children’s Research
Institute Animal Ethics Committees.
Screening germ cell development by flow cytometric
analysis
Initially in a series of single pass experiments (n=1, 4 go-
nads per culture) we screened 18 small molecule inhibitors
for their ability to disrupt male germ cell development in
fetal mouse testes. Testes were isolated from E12.5 Oct4-
GFP positive mouse fetuses and cultured for 72 hours in
the presence of inhibitor or vehicle control (e.g. dimethyl
sulphoxide; DMSO) using a culture system we have
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targeted a range of common signaling pathways, including
those mediated by (or through) platelet derived growth factor
(PDGF), glycogen synthase kinase 3 beta (GSK3β), mitogen
activated protein kinase (MAPK), phosphatidylinositol
3-kinase (PI3K), janus kinase (JAK), vascular endothelial
growth factor (VEGF) and ACTIVIN/NODAL/TGFβ.
At the end of the culture period the gonads were labeled
for two hours with 5-ethynyl-2′deoxyuridine (EdU),
which marks cells progressing through S-phase.
After 72 hours of culture we examined gonadal pheno-
type in whole mount to identify overall effects of the in-
hibitors on gonad development. Testis cord morphology
was viewed under phase contrast microscopy, while
germ cells were viewed in-situ using GFP fluorescence,
which is driven by germ cell specific expression of the
Oct4-GFP transgene (Figure 1A). The gonads were then
dissociated and subject to flow cytometric assessment ofFigure 1 Screening germ cell development using organ culture and f
middle) and fluorescence (lower middle) images of E12.5 testes cultured fo
separated on the basis of MVH staining and proliferation of (ii) germ cells a
PD0325901 treated gonad samples cultured for 72 hours.germ cell mitotic arrest, used in this context as a marker
of male germ cell differentiation (Figure 1B) [15,16].
Flow cytometric analysis of the gonads treated in these
cultures revealed that the two most effective inhibitors
of male germ cell mitotic arrest were SB431542 and
PD0325901, which inhibit the ACTIVIN/TGFβ/NODAL
receptors ALK4, ALK5 and ALK7, and MEK1/2 signaling,
respectively. Treatment with SB431542 or PD0325901
resulted in 14.5% and 13.5% of the germ cell population in-
corporating 5′-ethynyl-2′-deoxyuridine (EdU) (i.e. tran-
siting S-phase) compared with 3.2% in DMSO (control)
treated gonads. Detailed analyses of the impacts of
SB431542 on male germ cell development has been
reported in detail elsewhere [22] (D. Miles, S. Wakeling
and P. Western unpublished data). Here we provide a
step-by-step protocol for screening similar chemical in-
hibitors and other reagents for their ability to disrupt
male germ cell development.low cytometry. A. Organ culture system showing brightfield (upper
r 72 hours. B. Flow cytometric output for (i) germ and somatic cells
nd (iii) somatic cells assessed by EdU staining in DMSO and
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This protocol is based on Click-iT Edu chemistry
(Invitrogen). Germ cells are separated from gonadal somatic
cells using an antibody specific for Mouse Vasa Homologue
(MVH) (AbCam Ab13840), detected using an alexa fluor
donkey-anti-rabbit 488 nm secondary antibody, but both the
primary and secondary antibody can be varied depending on
your target cell (eg anti-SOX9 can be used to isolate Sertoli
cells and anti-FOXL2 or anti-GATA4 can be used for female
somatic cells), flow cytometer and preference for secondary
detection. This protocol is written for analysis of germ cells







5. Go1.1: Prepare 2.0 ml culture medium containing
either the vehicle control (e.g. typically DMSO
or PBS, depending on the solubility of the
inhibitor), or the inhibitor diluted at a 10 fold
higher concentration than the IC-50 as declared
by the manufacturer. For some compounds this
may not be known and must be determined
empirically. Pipette 1.5 ml culture medium into
the inner well of a Nunc organ culture dish and
place an organ culture filter over the well,
overlapping the well edges and covering the
medium. Culture medium should wet, but not
cover membrane. Fill outer well of the organ
culture dish with 4 ml sterile PBS to maintain
humidity and store in the cell culture incubator
until further use.
1.2: In an aseptic environment (eg laminar flow
hood) dissect the required number of fetal
gonads from E12.5 mouse embryos in PBS and
separate gonads from mesonephros. You can use
either gonad only or gonad with mesonephros
attached for the culture. In our experience germ
cells in E12.5 fetal testis/mesonephros and E12.5
testis only samples enter mitotic arrest with
similar efficiency. Using testis only allows
effects on both the germ cell and somatice 1 Flow cytometry controls
rol sample EdU Stain Purp
sonephroi × 4 No • Click-iT 647 Nega
• MVH-alexa fluor 488
• Propidium iodide




• MVH-alexa fluor 488
• Propidium iodide
sonephroi × 2 (optional) Yes • Click-iT 647 only Single
sonephroi × 2 (optional) No • Propidium iodide only Single
nads × 2 (optional) No • MVH-alexa fluor 488 only Singlecompartments of the testis to be monitored
simultaneously in the screening process.
1.3: Collect tissue for flow cytometry controls as
outlined in Table 1.
1.4: Place 2–4 gonads onto each membrane
(screening can be done with two gonads, but
four provides better germ cell numbers at the
end of the flow cytometric analysis). Culture
gonads in a 5% CO2/air environment, at 37°C
for 72 hours. Change medium daily to ensure
activity of inhibitor is maintained.
1.5: Two hours before the end of the culture period
add 1.5 μL 10 mM EdU to all samples except
the EdU negative control and the MVH alexa
fluor 488 positive control (optional) and the PI
single colour control (optional) (Table 1).
Incubate for two hours at 37°C.
1.6: After two hours of EdU treatment remove all
culture medium and replace with PBS and
remove gonads from the membrane by washing
them off the membrane into the culture dish
using a 1 ml pipette. Inspect and photograph
under low power on an inverted fluorescence/
bright field equipped microscope. Once you
have the desired images collect gonads into a
1.5 ml micro-centrifuge tube for flow cytometry.
We use maximum recovery tubes, but standard
tubes can also be used.
2. Staining for flow cytometry
The following protocol requires around four hours
depending on the number of samples.
2.1: Allow gonad and mesonephros samples to settle
and wash once with PBS. Remove PBS and add
100 μL of 0.25% trypsin.
2.2: Incubate at 37°C for 5 mins, gently flicking tube
approximately every 2 minutes or use a shaking
heating block.
2.3: Transfer tubes to ice, add 500 μL of DMEM/
10% FCS and dissociate cells by pipetting. Filter
cells through cell filter (BD 352235) into aose
tive sample for establishing gates in the 647 nm and 488 nm channels
ve controls for setting the laser power in the 488 nm and
m channels. Use females gonads for this if concentrating of male
cell development and vice-versa if concentrating on female germ
evelopment (or a mix, if concentrating on both).
color control for staining compensation
color control for staining compensation




Table 2 EdU-Click-iT labeling mix
Component Volume / tube
PBS 175 μL
CuSO4 (100 mM) 4 μL
647nm dye azide 1 μL
Reaction buffer additive 20 μL
Total volume 200 μL
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and filter with 200 μL extra DMEM/10% FCS.
Collect cells at 3500 rpm (1000g) in a fixed
angle bench-top centrifuge for 1 min. Rotate
micro-centrifuge tube 180 degrees and spin
again for 2 mins. Cells will form pellet at one
side of tube base. Carefully remove supernatant
from opposite pellet, leaving 10 ul behind.
2.4: Resuspend in 100 μL of fixative (4%
Paraformaldehyde in PBS) for 15 mins at room
temperature (RT). Collect cells at 5000 rpm
(2500 g) 10 seconds at RT. Rotate micro-
centrifuge tubes 180 degrees and spin again for
10 seconds.
2.5: Wash cells in 100 μL of permwash (supplied as
part of the Click-iT-EdU 647 Flow Cytometry
kit). Collect cells at 5000 rpm 10 seconds.
Rotate tubes 180 degrees and spin again for 10
seconds. Repeat one more time. (Potential
stopping point: Cells can be stored in permwash
for at least one week if staining for MVH)
2.6: Spin down and then resuspend again in 50 μL
permwash with 10% donkey serum (or
appropriate species serum for secondary
antibody). Incubate for 10–20 mins at RT.
2.7: Collect cells at 5000 rpm 10 seconds. Rotate
tubes 180 degrees and spin again for 10 seconds.
Resuspend in 25 μL permwash containing anti-
MVH antibody diluted 1/500. Incubate for 30–
45 mins at room temperature (RT).
2.8: Add 100 μL of permwash to each tube and spin
at 5000 rpm 10 seconds. Rotate tubes 180
degrees and spin again for 10 seconds.
2.9: Wash cells in 100 μL of permwash. Collect cells
at 5000 rpm 10 seconds. Rotate tubes 180
degrees and spin again for 10 seconds. Repeat
one more time.
.10: Resuspend in 25 μL permwash containing donkey
anti-rabbit secondary antibody (donkey anti-
rabbit 488 nm) diluted 1/300. Incubate for 30–45
mins at RT in the dark.
.11: Add 100 μL of permwash to each tube and spin
at 5000 rpm 10 seconds. Rotate tubes 180
degrees and spin again for 10 seconds.
.12: During washing prepare the 1× Click-iT EdU
reaction buffer additive by diluting 1:10 in
MilliQ water and the Click-iT reaction cocktail
according Table 2. The reaction cocktail should
be added to the cells within 15 mins of
preparation, so don’t prepare too early (volumes
in table can be scaled according to sample size).
.13: Wash cells in 100 μL of permwash. Collect cells
at 5000 rpm 10 seconds. Rotate tubes 180
degrees and spin again for 10 seconds.2.14: Add 200 μL of Click-iT reaction cocktail
(Table 2) to each tube and mix well.
2.15: Incubate for 30 minutes at RT in the dark.
2.16: Collect cells at 5000 rpm 10 seconds. Rotate
tubes 180 degrees and spin again for 10 seconds.
Wash cells once in 100 μL of permwash.
2.17: Add 400 μL permwash containing 4 μL 5 mg/ml
PI and 1.0 μL 20 mg/ml RNaseA.
3. Flow cytometric analysis
Perform flow cytometry using the following
protocol. Once you know how to use the flow
cytometer, you will require about 20 mins to set up
gates and 3–5 mins per sample running time. Set up
gates running samples on low speed, and analyse
your samples on medium-high.
3.1: Using the control sample 1 (Table 1) establish a
side scatter vs forward scatter plot. Isolate cells
from debris using gate P1 (Figure 2A). Display
cells from P1 in a new scatter plot of PI width
(linear) vs PI area (linear) (Figure 2B).
3.2: Using P1 as the parent population, establish a
gate (P2) around the single cells as shown in
Figure 2B. Set PI intensity so that the G1
population is located over 50 to100 and G2/M
population is located over 100 to 200
fluorescence units (Figure 2B). This value is not
critical, as long as sufficient separation is
achieved using PI to model cell cycle in a third
party software such as ModFit or FlowJo.
3.3: Showing only the P2 events and using P2 as
the parent population, establish a scatter plot
for alexa-flour 488 nm (log scale) vs PI
(PE-Cy5) area (linear scale). Set 488 nm laser
power so that the 488 nm negative somatic cells
are below just 1000.
3.4: Change to control sample 2 (Table 1). You
should see MVH positive germ cells in the
1000–10,000 range. Expect the staining
intensity for MVH to be a little higher in males
than females and higher at E15.5 than at E12.5.
In an untreated E12.5 samples cultured for 72
hours most of the MVH positive cells should
be located over the G1 PI value (ie over







Figure 2 Examples of gating strategy for flow cytometric analysis of fetal germ cells and gonadal somatic cells based on a PBS treated
control sample. A. Side vs forward scatter plot showing gate P1 around cells and excluding cell debris. B. Propidium iodide in the PE-Cy5 width
vs propidium iodide in the PE-Cy5 area showing events from P1, with single cells gated within P2. C. MVH-alexa fluor 488 vs propidium iodide
area showing events from P2, with germ cells (MVH positive) gated in P3 and somatic (MVH negative) cells gated in P4. D. EdU-Click-iT 647 in the
APC-area channel vs propidium iodide area showing events from P3 (ie germ cells), with proliferating (EdU positive) cells gated in P5. E. EdU-Click-iT 647
in the APC-area channel vs propidium iodide area showing events from P4 (ie somatic cells), with proliferating (EdU positive) cells gated in P6.
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positive cells, extending above the 488 negative
cells and incorporating PI values approximately
50–300 to ensure all cells are included in
treated samples to be analysed (Figure 2C).
These are the germ cells. Establish a similar gate
(P4) around the MVH 488 nm negative cells.
These are the somatic cells.
.6: To assess germ cell proliferation establish a scatter
plot for EdU (APC) area 647 nm (log scale) vs PI
(PE-Cy5) area (linear scale), showing only the P3
events. Set 647 nm laser power so that the 647 nm
negative cells are below just 1000. Using P3 (germ
cells) as the parent population, establish a gate (P5)
around the 647 nm positive cells. P5 contains germ
cells passing through S-phase in the two-hour
culture period during which the gonads were
exposed to EdU (Figure 2D).
.7: To assess somatic cell proliferation establish
another plot, similar to that established for germ
cells in 3.6. Showing only the P4 events establish
a scatter plot for EdU (APC) area 647 nm
(log scale) vs PI (PE-Cy5) area (linear scale).
Set 647 nm laser power so that the 647 nm
negative cells are below just 1000. Using P4
(somatic cells) as the parent population,establish a gate around the EdU (APC) area
647 nm positive cells (Figure 2E). P6 should
be essentially identical to the somatic cell P5 gate,
but specific for the somatic cells. These are
the somatic cells passing through S-phase
in the two-hour culture period during
which the gonads were exposed to EdU.
.8: Using control sample 1 (Table 1) check your P3,
P4, P5 and P6 gates to ensure they are correctly
established.
.9: Run samples
.10: Analyse data accordingly. You can analyse the
percentage of EdU positive germ cells and
somatic cells in each sample. You can also
perform cell cycle analysis based on PI staining
for the germ cell and somatic cell populations
using ModFit, FlowJo or similar programs. For
example, in a comprehensive analysis using
DMSO and the inhibitor SB431542 to treat
gonads in culture, 3.2 ±0.6% (SEM, n=10
cultures) and 14.3 ±3.3 (SEM, n=10) (p<0.001)
of the germ cells incorporated EdU, respectively.
However, in the somatic cell population 15.9% ±
0.6 (SEM, n=10) and 12.3 ± 0.81% (SEM, n=10)
of the DMSO and SB431542 treated cells
incorporated EdU, respectively (p<0.001) [22].
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Over recent decades male reproductive health has de-
clined and it has been suggested that various chemicals
or environmental toxins may be responsible through
their ability to disrupt testis and germ-line development
[23]. This is manifest in increased incidence of pluripo-
tent germ cell tumours, which have their origin in poorly
differentiated fetal germ cells. Male germ cell differenti-
ation is initiated and directed by unknown signaling pro-
cesses within the fetal testis, which results in strict
regulation of germ cell proliferation and the repression
of germ cell pluripotency. Although these signaling pro-
cesses are poorly understood, disruption of male germ
cell development at this stage can lead to pluripotent
germ cell tumours [19,20].
A tractable and sensitive model that facilitates rapid
screening of signaling inhibitors, environmental toxins
(e.g. endocrine disruptors) or other reagents that result in
compromised testis and/or germ cell development would
be of significant benefit in male reproductive biology. We
have combined our existing flow cytometric method with
gonad organ culture to develop a drug screening protocol
that facilitates identification of key signaling pathways in
testis and male germ cell development. Our model pro-
vides a means to rapidly screen drugs that affect the early
processes in testis and male germ cell development and
allow the analysis of perturbed germ cell differentiation in
a compromised testicular environment.
By using E12.5 rather than E11.5 testes this protocol
provides a method for perturbing germ cell develop-
ment after somatic sex determination, reducing the
complicating factors introduced by sex-reversal. The
flow cytometric assay allows robust detection of small
changes in cell proliferation in small amounts of tissue
(2–4 gonads are sufficient). As quality antibodies suitable
for flow cytometry are commercially available and/or
existing transgenic mouse models provide access to vari-
ous testis specific cell types (i.e. germ cells, Sertoli cells,
endothelial cells, Leydig cells) [24], this approach is
applicable to screening many inhibitors, endocrine
disruptors or other reagents that might impact testis or
germ cell development.
To test the veracity of the screening approach we initially
screened 20 inhibitors of common signaling pathways for
their ability to disrupt male germ cell development in
the early testis, soon after male sex determination. We
identified an important role for ACTIVIN/NODAL/TGFβ
signaling pathways in male germ cell development, which
we analyzed in detail in a separate study [22]. We also
identify negative affects on mitotic arrest of fetal male
germ cells using the MEK1/2 (MAPK) inhibitor germ cell
PD0325901 (S. Wakeling, D. Miles and P. Western, un-
published data) and are now performing a more detailed
analysis of this pathway.Following identification of drugs or chemicals that ex-
hibit activity in this screening protocol, further detailed
analyses, including immunofluorescence, qRTPCR and
cell biological assays can be performed to establish the
mechanisms through which the inhibitor is active. Given
appropriate antibodies for flow cytometry, a similar ap-
proach could be applied to other stages of gonad develop-
ment and may allow identification of drugs, chemicals or
toxins leading to reduced fertility and germ cell function.
We have applied this screening approach to ex-vivo gonad
cultures in mice because germ cell development is best
characterized in this species and ex-vivo screening facili-
tates a higher throughput system. However, the same ap-
proach can be applied to mice using in-vivo treatment, or
a similar approach could be used in other species.
We have developed a robust protocol facilitating
medium throughput screening of chemical inhibitors
that can be used to identify signaling pathways in-
volved in male germ cell development. This model pro-
vides an accessible system in which environmental and
developmental processes influencing testis and male
germ cell development can be manipulated and will
provide important insights into the processes under-
lying testicular dysgenesis and the early stages of germ
cell tumour formation.
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